Skin, repair & inflammation stack
A research blend of GHK-Cu, KPV, BPC-157 and TB-500 studied across dermal remodeling, inflammation modulation and connective-tissue repair models.
Quantity
Dose
Women's research notes
KLOW's combined research profile spans copper-peptide skin and hair literature, KPV anti-inflammatory dermal and gut research, plus BPC-157 and TB-500 connective-tissue repair work — areas with strong representation in women's health research.
Estrogen decline at menopause is associated with measurable losses in dermal collagen. GHK-Cu has been studied in fibroblast and topical models for collagen and elastin gene expression, while KPV is referenced in research on inflammatory dermal conditions that disproportionately affect women.
KPV and BPC-157 have been examined in pre-clinical models of intestinal inflammation and barrier integrity — relevant to functional gut conditions over-represented in women.
Female pattern hair thinning and post-procedure dermal recovery research have referenced copper-peptide work alongside TB-500 / thymosin beta-4 angiogenesis and BPC-157 connective-tissue repair literature.
